GOVX:NASDAQ
Geovax Labs Inc
$0.28
arrow_downward
-0.81%(-0.0023) 1D
Oct 13, 12:32:48 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.28
High
$0.29
Low
$0.28
Mkt. cap
2.57M
Avg. vol.
732.45K
Volume
101.56K
52-wk high
$15.75
52-wk low
$0.27
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
Open
$0.28
High
$0.29
Low
$0.28
Mkt. cap
2.57M
Avg. vol.
732.45K
Volume
101.56K
52-wk high
$15.75
52-wk low
$0.27
EPS
-$13.92
Beta
3.69
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
巴士的報
·
32 minutes ago
NYSE Touches Down at TechCrunch Disrupt: NYSE Content Update
The Seattle Times
·
32 minutes ago
The first big batch of US profit reports for the summer has Wall Street mixed
MarketBeat
·
3 minutes ago
PTC Therapeutics (NASDAQ:PTCT) Reaches New 12-Month Low - Time to Sell?
Bloomberg.com
·
2 hours ago
S&P 500 Record Rally Meets Risk of Peaking Earnings Growth
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com